Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
822.00Prev. Close
820.65Volume
60,710Total traded value
5.03 CrUpper Circuit
984.75Lower Circuit
656.55Fundamentals
| Market Cap | ₹1,730Cr |
| ROE | 12.60% |
| P/E Ratio(TTM) | 25.70 |
| EPS(TTM) | 31.94 |
| P/B Ratio | 3.24 |
| Dividend Yield | 0.70% |
| Industry P/E | 33.43 |
| Book Value | 253.39 |
| Debt to Equity | 0.06 |
| Face Value | 5 |
Understand Fundamentals
Financials
About Windlas Biotech
Windlas Biotech is a leading Contract Development and Manufacturing Organisation (CDMO) in the generic formulations sector, providing integrated and affordable healthcare solutions focused on quality. The company's operations are guided by a performance mindset rooted in consistency, which defines its approach to growth, value delivery, and creating long-term impact. Demonstrating its resilient business model, the company has achieved a significant milestone by marking nine consecutive quarters of record-breaking revenue and sustained operating margins.;
| Parent Organisation | Windlas Biotech |
| NSE Symbol | WINDLAS |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.73 | ||
| Ajanta Pharma | NA (0.00%) | 32.38 | ||
| Gland Pharma | NA (0.00%) | 38.17 | ||
| Eris Lifesciences | NA (0.00%) | 47.03 |